Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ryuji Hamamoto, Katsunori Takagi et al.|Cancer Science|2011Cited by 191
Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G1/S transitionMasaharu Kogure, Ryuji Hamamoto, Masashi Takawa et al.|Cancer Letters|2013Cited by 69